US Irritable Bowel Syndrome Treatment Market
US Irritable Bowel Syndrome Treatment Market Research Report By Type (IBS-D, IBS-C, IBS-M), By Drug Type (Lubiprostone, Linaclotide, Rifaximin, Eluxadoline, Alosetron), and By End-user (Hospitals, Clinics, Research Laboratories, Others) - Forecast to 2035.
US Irritable Bowel Syndrome Treatment Market Overview
As per MRFR analysis, the US Irritable Bowel Syndrome Treatment Market Size was estimated at 407.88 (USD Million) in 2023. The US Irritable Bowel Syndrome Treatment Market is expected to grow f..